Literature DB >> 11785501

Study of influenza-associated encephalitis/encephalopathy in children during the 1997 to 2001 influenza seasons.

H Yoshikawa1, S Yamazaki, T Watanabe, T Abe.   

Abstract

The 1997 to 2001 influenza A epidemics in Japan were markedly neurovirulent, and many children died of influenza-associated encephalitis/encephalopathy. We studied 20 patients with influenza-associated encephalitis/encephalopathy during the last four influenza seasons. No patients had been previously inoculated with influenza vaccine. Antipyretics were used in 16 patients before the onset of encephalopathy. Although all patients were treated intensively, 5 patients died and 8 had neurologic sequelae. Patients with coagulopathy, hepatic dysfunction, and computed tomographic abnormalities had a poor prognosis. The plasma concentrations of inflammatory cytokines were variable. The neuroradiologic findings could be divided into four categories. These findings indicated that the pathogenesis of the brain damage induced by influenza infection was variable. Further investigation is necessary to determine whether insufficient influenza vaccination or the use of antipyretics is one of the reasons for these epidemics of encephalopathy in Japanese children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11785501     DOI: 10.1177/088307380101601204

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  19 in total

1.  Concentric thalamic change on MR of acute necrotising encephalopathy of childhood.

Authors:  H-S Wang
Journal:  Neuroradiology       Date:  2003-08-02       Impact factor: 2.804

Review 2.  Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review.

Authors:  Jun-ichi Takanashi; A James Barkovich; Ken-ichi Yamaguchi; Yoichi Kohno
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

3.  Are neuroimaging findings in novel influenza A(H1N1) infection really novel?

Authors:  R K Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2010-03       Impact factor: 3.825

4.  MR imaging in novel influenza A(H1N1)-associated meningoencephalitis.

Authors:  A Haktanir
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

Review 5.  Neuroinflammation During RNA Viral Infections.

Authors:  Robyn S Klein; Charise Garber; Kristen E Funk; Hamid Salimi; Allison Soung; Marlene Kanmogne; Sindhu Manivasagam; Shannon Agner; Matthew Cain
Journal:  Annu Rev Immunol       Date:  2019-04-26       Impact factor: 28.527

6.  Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy.

Authors:  N Bulakbasi; M Kocaoglu; C Tayfun; T Ucoz
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

7.  Extraordinary changes in excitatory amino acid levels in cerebrospinal fluid of influenza-associated encephalopathy of children.

Authors:  Hisashi Kawashima; Tsuneo Morishima; Takehiro Togashi; Shunpei Yokota; Gaku Yamanaka; Hiroaki Ioi; Yasuyo Kashiwagi; Kouji Takekuma; Akinori Hoshika; Yasuo Watanabe
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

Review 8.  Prematurity and the burden of influenza and respiratory syncytial virus disease.

Authors:  Bernhard Resch; Stefan Kurath-Koller; Monika Eibisberger; Werner Zenz
Journal:  World J Pediatr       Date:  2015-11-19       Impact factor: 2.764

9.  Acute necrotizing encephalopathy.

Authors:  Sucheta Yadav; Chandan Jyoti Das; Vikram Kumar; Rakesh Lodha
Journal:  Indian J Pediatr       Date:  2009-11-20       Impact factor: 5.319

10.  Prevalence, Risk Factors, and Outcomes of Influenza-Associated Neurologic Complications in Children.

Authors:  James W Antoon; Matt Hall; Alison Herndon; David P Johnson; Charlotte M Brown; Whitney L Browning; Todd A Florin; Leigh M Howard; Carlos G Grijalva; Derek J Williams
Journal:  J Pediatr       Date:  2021-07-01       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.